A phase I dose-escalation study of etoposide continuous infusion added to busulphan/cyclophosphamide as conditioning prior to autologous or allogeneic stem cell transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/12420202

Download in:

View as

General Info

PMID
12420202